Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS · Delayed Price · Currency is USD
13.74
-0.01 (-0.07%)
At close: Jan 29, 2026
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $22.06 million as of January 30, 2026. Its market cap has increased by 11.89% in one year.
Market Cap
22.06M
Enterprise Value
35.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$13.74
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 22.06M, a decrease of -97.80%. That is a compound annual growth rate of -54.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 22.06M | 1.88% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | 1.01B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LakeShore Biopharma | 35.23M |
| Ayala Pharmaceuticals | 33.80M |
| Harvard Apparatus Regenerative Technology | 29.54M |
| EOM Pharmaceuticals Holdings | 24.04M |
| Provectus Biopharmaceuticals | 21.43M |
| Zeo ScientifiX | 20.30M |
| Zenith Capital | 15.97M |
| GPL Holdings | 13.61M |